Intelligence Driven Advisers LLC Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Intelligence Driven Advisers LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 452 shares of the healthcare conglomerate’s stock, valued at approximately $264,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the 3rd quarter valued at $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.5 %

NYSE UNH traded down $2.92 during trading hours on Thursday, reaching $602.95. 127,597 shares of the company traded hands, compared to its average volume of 3,877,753. The stock has a market capitalization of $554.88 billion, a PE ratio of 39.47, a PEG ratio of 1.80 and a beta of 0.58. The company has a 50 day moving average of $582.99 and a two-hundred day moving average of $548.03. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on UNH. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Argus upped their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.